IL177754A0 - Phenylethanolamine derivatives as beta-2 agonists - Google Patents

Phenylethanolamine derivatives as beta-2 agonists

Info

Publication number
IL177754A0
IL177754A0 IL177754A IL17775406A IL177754A0 IL 177754 A0 IL177754 A0 IL 177754A0 IL 177754 A IL177754 A IL 177754A IL 17775406 A IL17775406 A IL 17775406A IL 177754 A0 IL177754 A0 IL 177754A0
Authority
IL
Israel
Prior art keywords
agonists
beta
phenylethanolamine derivatives
phenylethanolamine
derivatives
Prior art date
Application number
IL177754A
Other languages
English (en)
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from EP04290725A external-priority patent/EP1577291A1/en
Priority claimed from GB0425064A external-priority patent/GB0425064D0/en
Priority claimed from PCT/IB2005/000640 external-priority patent/WO2005090287A2/en
Application filed by Pfizer filed Critical Pfizer
Publication of IL177754A0 publication Critical patent/IL177754A0/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C237/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups
    • C07C237/02—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton
    • C07C237/20—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton containing six-membered aromatic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
    • C07D217/02—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with only hydrogen atoms or radicals containing only carbon and hydrogen atoms, directly attached to carbon atoms of the nitrogen-containing ring; Alkylene-bis-isoquinolines
    • C07D217/06—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with only hydrogen atoms or radicals containing only carbon and hydrogen atoms, directly attached to carbon atoms of the nitrogen-containing ring; Alkylene-bis-isoquinolines with the ring nitrogen atom acylated by carboxylic or carbonic acids, or with sulfur or nitrogen analogues thereof, e.g. carbamates

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pulmonology (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
IL177754A 2004-03-17 2006-08-29 Phenylethanolamine derivatives as beta-2 agonists IL177754A0 (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
EP04290725A EP1577291A1 (en) 2004-03-17 2004-03-17 Phenylethanolamine derivatives as beta-2 agonists
US59179004P 2004-07-27 2004-07-27
GB0425064A GB0425064D0 (en) 2004-11-12 2004-11-12 Compounds useful for the treatment of diseases
PCT/IB2005/000640 WO2005090287A2 (en) 2004-03-17 2005-03-10 Phenylethanolamine derivatives as beta-2 agonists

Publications (1)

Publication Number Publication Date
IL177754A0 true IL177754A0 (en) 2006-12-31

Family

ID=34961252

Family Applications (1)

Application Number Title Priority Date Filing Date
IL177754A IL177754A0 (en) 2004-03-17 2006-08-29 Phenylethanolamine derivatives as beta-2 agonists

Country Status (13)

Country Link
KR (1) KR20070026420A (es)
AP (1) AP2006003743A0 (es)
AR (1) AR048267A1 (es)
EC (1) ECSP066854A (es)
IL (1) IL177754A0 (es)
MA (1) MA28475B1 (es)
NL (1) NL1028559C2 (es)
NO (1) NO20063875L (es)
PA (1) PA8626401A1 (es)
PE (1) PE20060123A1 (es)
SV (1) SV2005002052A (es)
TW (1) TWI281396B (es)
UY (1) UY28810A1 (es)

Also Published As

Publication number Publication date
ECSP066854A (es) 2006-11-24
NL1028559A1 (nl) 2005-09-20
NL1028559C2 (nl) 2006-04-19
SV2005002052A (es) 2005-12-13
NO20063875L (no) 2006-09-26
AR048267A1 (es) 2006-04-12
PE20060123A1 (es) 2006-03-08
KR20070026420A (ko) 2007-03-08
AP2006003743A0 (en) 2006-10-31
UY28810A1 (es) 2005-10-31
PA8626401A1 (es) 2006-05-16
TWI281396B (en) 2007-05-21
MA28475B1 (fr) 2007-03-01
TW200534846A (en) 2005-11-01

Similar Documents

Publication Publication Date Title
ZA200802495B (en) Alpa2C adrenoreceptor agonists
GB0522715D0 (en) New use
HK1124233A1 (en) Quinoline derivatives as antibacterical agents
PL2175273T3 (pl) Środek nadający kokumi
ZA200707650B (en) Azolylacylguanidines as ß-secretase inhibitors
EP1901733A4 (en) USE OF HUPERZINE FOR DISEASES
EP1950309A4 (en) ALBUMIN DENATURING AGENCY
IL182739A0 (en) Acylatednonadepsipeptides used as lysobactin derivatives
EP1927347A4 (en) MEANS TO REDUCE BITTERNESS
EP1889660A4 (en) OZONE-GROWING AGENT
GB0520176D0 (en) Use
GB0511190D0 (en) Use
GB0500828D0 (en) Benzamide derivatives
GB0501146D0 (en) Novel benzamide derivatives
GB0506001D0 (en) Novel use
AU302871S (en) Clip
GB0526552D0 (en) New use
GB0518232D0 (en) New methods
GB0502250D0 (en) Use
ZA200801208B (en) Anti-malarial composition
GB0526031D0 (en) Use
GB0526032D0 (en) Use
EP1933850A4 (en) APTAMERS AS AGONISTS
EP1846443A4 (en) NEW USE
IL177754A0 (en) Phenylethanolamine derivatives as beta-2 agonists